Targeting iron to contrast cancer progression.
Curr Opin Chem Biol
; 74: 102315, 2023 06.
Article
em En
| MEDLINE
| ID: mdl-37187095
ABSTRACT
An altered metabolism of iron fuels cancer growth, invasion, metastasis, and recurrence. Ongoing research in cancer biology is delineating a complex iron-trafficking program involving both malignant cells and their support network of cancer stem cells, immune cells, and other stromal components in the tumor microenvironment. Iron-binding strategies in anticancer drug discovery are being pursued in clinical trials and in multiple programs at various levels of development. Polypharmacological mechanisms of action, combined with emerging iron-associated biomarkers and companion diagnostics, are poised to offer new therapeutic options. By targeting a fundamental player in cancer progression, iron-binding drug candidates (either alone or in combination therapy) have the potential to impact a broad range of cancer types and to address the major clinical problems of recurrence and resistance to therapy.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Ferro
/
Neoplasias
Limite:
Humans
Idioma:
En
Revista:
Curr Opin Chem Biol
Ano de publicação:
2023
Tipo de documento:
Article